Clinical Trials Browser

Phase 2 × Lung Neoplasms × tanespimycin × Clear all

NCT01228435 2017-12-04

IPI-504 in NSCLC Patients With ALK Translocations

Phase 2 Terminated

3 enrolled 5 charts

Lung Neoplasms

NCT01362400 2014-05-19

A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell